3B BlackBio Dx has scheduled its 54th Annual General Meeting for September 29, 2026. The meeting will convene to adopt the audited financial statements for FY26 and declare a final dividend of ₹5 per equity share.

The company, formerly known as Kilpest India Limited, will hold the meeting via Video Conferencing or Other Audio Visual Means at 11:30 am IST. Shareholders on record as of September 22, 2026, will be eligible for the dividend payout and voting rights.

Key Agenda Items

The ordinary business includes the adoption of standalone and consolidated financial statements for the year ended March 31, 2026. The Board recommends the final dividend out of current profits, subject to member approval.

Special business items focus on governance and audit compliance:

• Reappointment of Mrs. Mithla Dubey as a Non-Executive Director liable to retire by rotation.
• Ratification of remuneration for Cost Auditors Sanjay Kasliwal & Associates.

Director Reappointment

Mrs. Mithla Dubey (DIN: 03597415), aged 79, seeks reappointment as a Non-Executive Director. Under SEBI Listing Regulations, a special resolution is required for directors aged 75 or above. She serves as a promoter and woman director, holding 10,59,770 equity shares as of March 31, 2026.

Audit Remuneration

The Board seeks ratification for a remuneration of ₹50,000 payable to Sanjay Kasliwal & Associates for conducting the cost audit for the financial year ending March 31, 2027. This appointment follows a recommendation by the Audit Committee.

What the Numbers Show

The declaration of a ₹5 final dividend represents a 50% payout rate relative to the face value of the equity shares. This distribution is contingent upon shareholder approval at the AGM and payment is scheduled for on or after October 5, 2026, subject to applicable tax deductions at source.

3B BlackBio Dx Limited will host a virtual investor conference call on Friday, September 11, 2026, at 11:00 am. The meeting is scheduled as a one-on-one interaction with Capri Global Holdings in Mumbai.

The company disclosed the schedule pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The interaction will be conducted via an investor conference call mode.

Meeting Details

The company confirmed that only information available in the public domain will be shared during the session. No unpublished price-sensitive information will be discussed.

Presentation Material

For this meeting, the company will use the Investor Presentation of Q1-FY27. This document was previously intimated to the stock exchange vide Ref.No.P-66/2026-27/27 dated August 13, 2026.

The disclosure was signed by Nikhil Kuber Dubey, Whole Time Director of 3B BlackBio Dx Limited (formerly Kilpest India Limited). The company noted that the date and time are subject to change due to exigencies on the part of the investor or the company.